State Ledger
Company profile

Adicet Bio, Inc. CIK 1720580

Ticker
ACET (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
Boston, MA 02116
Fiscal year end
2025 (FY)
Market Data
Close
$5.66
Change
-$0.05
Change %
-0.88%
Volume
8,747

ACET · trading date Oct 9, 2026 · previous close $5.71 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
—
Net income
-$116.80M
Total assets
$192.36M
Total liabilities
$33.15M
Stockholders' equity
$159.21M
Cash & equivalents
$38.92M
Operating income
-$122.11M
Operating cash flow
-$95.25M
Capital expenditures
$1.74M

Fiscal year 2025, via 10-K filed 2026-03-12. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
—
Net margin
—
Free cash flow
-$96.98M
Free cash flow margin
—
Liabilities / assets
17.2%
Equity / assets
82.8%
CapEx / revenue
—
Operating cash flow / net income
0.82×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 — -$116.80M $192.36M $33.15M $159.21M
2024 — -$117.12M $220.22M $33.61M $186.61M
2023 — -$142.66M $207.30M $37.12M $170.18M
2022 — -$69.79M $330.69M $38.35M $292.34M
2021 — -$62.00M $338.94M $35.81M $303.13M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-08
Financials filed via
Form 10-K
filed 2026-03-12

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
Boston, MA 02116
131 DARTMOUTH STREET
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:34 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Massachusetts — Public Companies